In vivo delta opioid receptor internalization controls behavioral effects of agonists

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Pradhan, Amynah A A ^a   Becker, Jérôme A J ^a   Scherrer, Grégory ^a,b   Tryoen Toth, Petra ^a,c   Filliol, Dominique ^a   Matifas, Audrey ^a   Massotte, Dominique ^a   Gavériaux Ruff, Claire ^a   Kieffer, Brigitte L ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRE DE NEUROCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ARM 390; DELTA OPIATE RECEPTOR; ENHANCED GREEN FLUORESCENT PROTEIN; G PROTEIN COUPLED RECEPTOR; METENKEPHALIN; OPIATE AGONIST; UNCLASSIFIED DRUG; 4 (ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL) N,N DIETHYLBENZAMIDE; 4-(ALPHA-(4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-METHOXYBENZYL)-N,N-DIETHYLBENZAMIDE; BENZAMIDE DERIVATIVE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LIGAND; N,N DIETHYL 4 (PHENYLPIPERIDIN 4 YLIDENEMETHYL)BENZAMIDE; N,N-DIETHYL-4-(PHENYLPIPERIDIN-4-YLIDENEMETHYL)BENZAMIDE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; ENDOCYTOSIS; INTERNALIZATION; MOUSE; NONHUMAN; PAIN; PHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANIMAL; ANIMAL BEHAVIOR; CELL CULTURE; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IN VITRO STUDY; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN CONFORMATION; TRANSGENIC MOUSE;

ANIMALIA; MUS;

ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CELLS, CULTURED; GREEN FLUORESCENT PROTEINS; LIGANDS; MICE; MICE, TRANSGENIC; NEURONS; PAIN; PHOSPHORYLATION; PIPERAZINES; PIPERIDINES; PROTEIN CONFORMATION; RECEPTORS, OPIOID, DELTA; RECOMBINANT FUSION PROTEINS;

EID: 65549156477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005425     Document Type: Article

References (46)

1. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3: 639-650.
2. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 1-24.
3. Bernard V, Decossas M, Liste I, Bloch B (2006) Intraneuronal trafficking of G-protein-coupled receptors in vivo. Trends Neurosci 29: 140-147.
4. Tan CM, Brady AE, Nickols HH, Wang Q, Limbird LE (2004) Membrane trafficking of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 44: 559-609.
5. Sorkin A, von Zastrow M (2002) Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol 3: 600-614.
6. Perry SJ, Lefkowitz RJ (2002) Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol 12: 130-138.
7. von Zastrow M (2003) Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway. Life Sci 74: 217-224.
8. Tappe-Theodor A, Agarwal N, Katona I, Rubino T, Martini L, et al. (2007) A molecular basis of analgesic tolerance to cannabinoids. J Neurosci 27: 4165-4177.
9. Sternini C, Spann M, Anton B, Keith DE Jr, Bunnett NW, et al. (1996) Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc Natl Acad Sci U S A 93: 9241-9246.
10. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, et al. (1998) mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53: 377-384.
11. Van Bockstaele EJ, Commons KG (2001) Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus. Neuroscience 108: 467-477.
12. Gastard M (2000) Delta-opioid receptor endocytosis in spinal cord after dermenkephalin activation. BMC Neurosci 1: 1.
13. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, et al. (2006) Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103: 9691-9696.
14. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, et al. (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200.
15. Kieffer BL, Gaveriaux-Ruff C (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66: 285-306.
16. Nadal X, Banos JE, Kieffer BL, Maldonado R (2006) Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur J Neurosci 23: 830-834.
17. Hurley RW, Hammond DL (2000) The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20: 1249-1259.
18. Fraser GL, Gaudreau GA, Clarke PB, Menard DP, Perkins MN (2000) Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation. Br J Pharmacol 129: 1668-1672.
19. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A (2003) Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101: 199-208.
20. Mika J, Przewlocki R, Przewlocka B (2001) The role of delta-opioid receptor subtypes in neuropathic pain. Eur J Pharmacol 415: 31-37.
21. Calderon SN, Rothman RB, Porreca F, Flippen-Anderson JL, McNutt RW, et al. (1994) Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxy-benzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 37: 2125-2128.
22. Wei ZY, Brown W, Takasaki B, Plobeck N, Delorme D, et al. (2000) N,N- Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues. J Med Chem 43: 3895-3905.
23. Marie N, Landemore G, Debout C, Jauzac P, Allouche S (2003) Pharmacological characterization of AR-M1000390 at human delta opioid receptors. Life Sci 73: 1691-1704.
24. Law PY (2004) Delta Opioid Receptor Signaling and Trafficking. In: Chang KJ, Porreca F, Woods JH, eds. The Delta Receptor. Marcel Dekker, Inc. pp 61-87.
25. Morinville A, Cahill CM, Aibak H, Rymar VV, Pradhan A, et al. (2004) Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci 24: 5549-5559.
26. Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent JP, et al. (2006) Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci 26: 953-962.
27. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, et al. (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 100: 7947-7952.
28. Gaveriaux-Ruff C, Karchewski LA, Hever X, Matifas A, Kieffer BL (2008) Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci 27: 2558-2567.
29. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27: 107-144.
30. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, et al. (2002) Modulation of postendocytic sorting of G protein-coupled receptors. Science 297: 615-620.
31. Malatynska E, Wang Y, Knapp RJ, Waite S, Calderon S, et al. (1996) Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80. J Pharmacol Exp Ther 278: 1083-1089.
32. Trapaidze N, Keith DE, Cvejic S, Evans CJ, Devi LA (1996) Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization. J Biol Chem 271: 29279-29285.
33. Ko JL, Arvidsson U, Williams FG, Law PY, Elde R, et al. (1999) Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. Brain Res Mol Brain Res 69: 171-185.
34. Hasbi A, Allouche S, Sichel F, Stanasila L, Massotte D, et al. (2000) Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism. J Pharmacol Exp Ther 293: 237-247.
35. Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, et al. (2000) Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 275: 32057-32065.
36. Kouhen OM, Wang G, Solberg J, Erickson LJ, Law PY, et al. (2000) Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization. J Biol Chem 275: 36659-36664.
37. Audet N, Gales C, Archer-Lahlou E, Vallieres M, Schiller PW, et al. (2008) Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 283: 15078-15088.
38. Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH (2005) Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl) -1-piperazinyl]-(3-methoxyphenyl) methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. J Pharmacol Exp Ther 315: 414-422.
39. Brandt MR, Furness MS, Rice KC, Fischer BD, Negus SS (2001) Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. J Pharmacol Exp Ther 299: 629-637.
40. Kieffer BL, Evans CJ (2002) Opioid tolerance-in search of the holy grail. Cell 108: 587-590.
41. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408: 720-723.
42. Trapaidze N, Gomes I, Cvejic S, Bansinath M, Devi LA (2000) Opioid receptor endocytosis and activation of MAP kinase pathway. Brain Res Mol Brain Res 76: 220-228.
43. He L, Fong J, von Zastrow M, Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108: 271-282.
44. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23: 737-746.
45. Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, et al. (2001) A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem 276: 3130-3137.
46. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.